We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fed. Circ. Kills Mylan's Prilosec Antitrust Claims

Law360 (March 8, 2011, 4:01 PM EST) -- The Federal Circuit on Tuesday rejected Mylan Laboratories Inc.'s bid to revive allegations that AstraZeneca AB violated antitrust law by filing sham patent infringement suits to protect its heartburn drug Prilosec....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.